1Kantor P,Lucien A,Kozak R,et al .The antiangial drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain-3-ketoacy1 coenzyme A thiolase .Circ Res,2000,86:580-588.
2Eugene B, Elliott M, John W,et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: Executive Summary and Recommendations. Circulation, 2000,102:1193-1209.
